Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It's never simple with these players, IMO

and company policys towards actions which foster a desirable Shareholder focused investment, and thereby Investor interest/Share support/demand, is behind us. Suggestions or actions at this point are too late. This board community as a whole has rejected them, and a smaller board community has rejected funding them.

Unfortunately, even with a win in the Courts, Shareholder's choice to not concertedly and more strongly exert their own self interests to the BOD will have ramifications going forward which I believe will become readily apparent during the window opportunities in selling those 410,000,000 shares.

Oh sure, with success in the Courts or the ITC the shares will rise from here

Good luck Ads

Share
New Message
Please login to post a reply